Cargando…
Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents
Stimuli-activatable photosensitizers (PSs) are highly desirable for photodynamic therapy (PDT) to selectively demolish tumor cells. On the other hand, lysosomes are emerging as attractive anticancer targets. Herein, four cyclometalated iridium(iii)–β-carboline complexes with pH-responsive singlet ox...
Autores principales: | He, Liang, Li, Yi, Tan, Cai-Ping, Ye, Rui-Rong, Chen, Mu-He, Cao, Jian-Jun, Ji, Liang-Nian, Mao, Zong-Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947539/ https://www.ncbi.nlm.nih.gov/pubmed/29861886 http://dx.doi.org/10.1039/c5sc01955a |
Ejemplares similares
-
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
por: Wang, Fang-Xin, et al.
Publicado: (2016) -
Cyclometalated
Ir(III) Complexes as Lysosome-Targeted
Photodynamic Anticancer Agents
por: Zhu, Jiayi, et al.
Publicado: (2023) -
Inhibition of autophagic flux by cyclometalated iridium(iii) complexes through anion transportation
por: Chen, Mu-He, et al.
Publicado: (2019) -
Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexes
por: Cao, Jian-Jun, et al.
Publicado: (2017) -
Lysosomal Targeted Cyclometallic Iridium(Ⅲ) Salicylaldehyde-Coumarin Schiff Base Complexes and Anticancer Application
por: Xu, Ruixi, et al.
Publicado: (2022)